| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |